Desc1.5
Acetaminophen, Caffeine, Dihydrocodeine Bitartrate
Product Images NDC 42195-840
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetaminophen, Caffeine, Dihydrocodeine Bitartrate (NDC 42195-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xspire Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Desc2.5
Desc3.5
This text refers to the molecular formula of a compound known as CigHpaNOg+ C4HGO5 with a molecular weight of 451.47. The compound's name and properties are not specified, so further information is needed to determine its characteristics and potential uses.*
Labl1.6
This is a description of medication in capsule form with the lot number and expiration date. The medication contains Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate. It is recommended to check the package insert for full prescribing information and keep the medication out of the reach of children. The medication should be stored in a tight, light-resistant container at 20° to 25°C and protected from moisture. The manufacturer is Xspire Pharma, LLC located in Ridgeland, MS 39157.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
